And our research team found that circ-ADD3 increased the interaction between CDK1 and EZH2, resulting in EZH2 phosphorylation and ubiquitination and degradation, inhibiting HCC metastasis [17]. The gene discussed is ADD3; the disease is hepatocellular carcinoma.